Project Grant HT94252310267
Award Date 5/1/23
Completion Date 4/30/26
Dollars Obligated $2M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Hanover, NH 03755, USA
Similar Awards
- This federal Project Grant award from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), provides $5,163,060.00 to Dartmouth-Hitchcock Clinic to conduct therapeutic targeting research on the tumor microenvironment in triple-negative breast cancer patients at high risk of relapse, as well as preclinical models of lung metastases. The research project aims to transform healthcare for military service members, veterans, and the broader public by...
- The Defense Health Agency awarded a $781,300.00 Project Grant titled "RELATIONSHIP OF METAL EXPOSURES TO HEALTH RISK MARKERS, MOOD, AND COGNITIVE FUNCTIONING IN MILITARY VETERANS" to Trustees of Boston University Medical Campus. The grant, funded under the Military Medical Research and Development program (CFDA 12.420), will support research to investigate the relationship between metal exposures, health risk indicators, mood, and cognitive functioning in military veterans. Dartmouth...
- The Defense Health Agency awarded a $487,765 Project Grant to The Johns Hopkins University under the Military Medical Research and Development program (CFDA 12.420) to develop "A NOVEL DIGITAL TWIN FOR OPTIMIZING NORMOTHERMIC VCA PRESERVATION". This 3-year research project, with a period of performance from September 30, 2025 to September 29, 2028, aims to advance biomedical research and innovation in healthcare solutions for military service members and the public. The Military...
- This Department of Defense (CFDA 12.420 - Military Medical Research and Development) Project Grant award of $2,499,990.00 was provided to the Dartmouth-Hitchcock Clinic, doing business as Dartmouth-Hitchcock Obligated Group, to conduct a multicenter randomized controlled trial evaluating the use of incisional negative pressure wound therapy to reduce infection and complications in high-risk fractures. The grant has an award date of September 1, 2023 and an ultimate completion date of August...
- The U.S. Defense Health Agency awarded a $1,723,552 Project Grant to the Beth Israel Deaconess Medical Center, Inc. (Bidmc) under the Military Medical Research and Development program (CFDA 12.420). The award, effective September 1, 2025 through August 31, 2028, will support research to target specific long non-coding RNAs (lncRNAs) in novel combined therapies to modulate the TSP1-dependent immune microenvironment vulnerabilities in advanced thyroid cancer. As a prominent non-profit academic...
- The U.S. Defense Health Agency awarded a $1,439,597 Project Grant to the Dartmouth-Hitchcock Clinic to fund the "Targeting Knowledge and Cognition to Improve Quality of Life: An Innovative Telehealth Approach for Brain Tumor Survivors and Their Care Partners" research project under the Military Medical Research and Development program (CFDA 12.420). This 4-year grant, commencing on May 1, 2025, will support the development and implementation of an innovative telehealth approach to...
- This $4,250,000.00 Cooperative Agreement was awarded on February 1, 2025 by the U.S. Department of the Army's Research Development and Engineering Command to the Trustees of Dartmouth College under the Basic Scientific Research program (CFDA 12.431). The grant supports fundamental research across scientific and technological domains critical to national security, with the goal of pursuing high-risk, high-payoff ideas in basic science to ensure dominant strategic land power. Dartmouth College,...
- This federal Project Grant award from the Department of the Army Materiel Command's Basic Scientific Research Program (CFDA 12.431) provides $180,000.00 in funding to the Trustees of Dartmouth College for the project "MATHEMATICALLY INTEGRATING NONLINEAR DECISIONS FOR SOCIAL EMOTIONAL TRANSITIONS" from February 1, 2025 through January 31, 2028. The grant supports fundamental research across scientific and technological domains critical to national security, with the goal of discovering...
- The Defense Health Agency awarded Brigham & Women's Hospital Inc. a $253,636 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 1, 2023 to June 30, 2025 to investigate the role of the secreted factor CTHRC1 in the pathogenesis of tuberous sclerosis complex. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public health care...
- Drexel University was awarded a $302,750 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from March 2021 through March 2024 to develop a novel microtubule-based hypothesis for frontotemporal dementia leading to potential therapies for military personnel and veterans. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform...